Pharmaceutical Sciences

Abdel Nasser Badawi Ibrahim Singab is the Chairman of Centre for Drug Discovery and Research Development and Professor Emeritus of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Egypt. Former Vice-president of Ain Shams University, dean of faculty of pharmacy. A member of the Supreme Committee of the Chinese Traditional Medicine (TCM). Among the best 2% of scientists worldwide in pharmacy, win state appreciation award. Member of editorial board of international scientific journals as well as reviewer. Have 122 international publications with h-index 20, research interest in drug discovery from natural products (marines and endophytes) Sophisticated chromatographic and spectroscopic techniques for isolation and identification of natural products (marine &plants), analysis of herbal drugs and phytotherapy.

His research interest is on Sophisticated chromatographic and spectroscopic techniques for isolation and identification of natural products (marine &plants), analysis of herbal drugs and phytotherapy

Prof. Dr. Heyam Saad Ali, Ph-D –She is working in the pharmaceutics department in Dubai Pharmacy College, UAE. Prof. contributed more than 70 articles to reputed international scientific journals and conferences, in different conventional, controlled and targeted drug delivery systems in pharmaceutical product development. She has been invited as a speaker at numerous International conferences.Reviewer and member of editorial board of many international journals.

pharmaceutics

Dr.Rajender Reddy Leleti, CEO of Sambi Pharma, He has over 25+ years of scientific research experience in process development, process optimization, cost-effective and safer route selection, synthesis of complex NCEs/APIs, total synthesis of biologically active molecules at Novartis Pharmaceuticals, Piramal Pharma Solutions, Sai Life Sciences, Harvard University, RWTH University and Scientifically trained by Nobel Laureates. He have published over 90 publications and patent. He is also a member of Ad-Hoc Board of Studies, Sardar Patel University, Gujarat and member of Scientific Advisory Council, Indrashil University, Gujarat.

Process Development, Process Optimization, cost-effective and safer route selection, synthesis of complex NCEs/APIs, total synthesis of Biologically Active Molecules.

George Schroeder MD, MS, FACEP, FAAUCM- Founder & President of Global Renaissance Enterprises, Corp. in Canada, & NARMPRO , LLC in USA He has served as Clinical Assistant Professor of Emergency Medicine at the University of Central Florida College of Medicine and Executive Director of Medical Affairs for the American Academy of Urgent Care Medicine. He has 33 years of experience in Emergency / Urgent Care Medicine Appointed to the International Scientific Advisory Board - Magellan BioScience & serves on Board of Directors of American Academy of Urgent Care Medicine. He is a certified SSI Open Water SCUBA Diver

Emergency Medicine and Urgent Care Medicine, Marine toxins and Natural product Bioactive marine molecules with Biopharmaceutical potential

Emmanuel O. Akala, R. Ph., Ph.D. is a Professor of Pharmaceutics, Chair, Howard University Institutional Animal Care and Use Committee (IACUC) and Director, Laboratory for Nanomedicine, Drug Delivery, and Pharmaceutical & Biopharmaceutical Drug Products Design. His training is cosmopolitan and his curriculum vitae (CV) provides details of his professional training as a pharmacist and an immunization pharmacist (registered in Utah, Maryland, Washington DC and in Nigeria), a pharmacy professor, and a research scientist with bias for conventional and novel drug delivery systems. Professor Akala received B. Pharm. (Hons) degree and M.Sc. (Pharmaceutics) degree at The University of Ife (Now Obafemi Awolowo University), Ile-Ife, Nigeria and Ph.D. degree in Pharmaceutics at The University of Manchester, England (as a Commonwealth Scholar). He was a DAAD Fellow at the Institute of Biopharmaceutics and Pharmaceutical Technology, University of Munster, Germany, and an NIH Postdoctoral Fellow in Pharmaceutics and Bioengineering at The University of Utah, USA. He has worked as a pharmacist in Nigeria and USA, and as a Lecturer and Senior Lecturer in Pharmaceutics in Nigeria, as a Teaching Assistant in England, as a Laboratory Instructor and Research Associate in USA and Germany and as an Assistant Professor, Associate Professor and Professor of Pharmaceutics in USA.

His research interests includes Controlled Drug Delivery and Drug Targeting, Drug Formulation and Stability Studies, Pharmacokinetics in Pharmaceutical Dosage Form Design, Pharmacokinetics in Pharmaceutical Dosage Form Design, Drug Formulation and Stability Studies, Biomaterials, Biopharmecutical Application of Nanotechnology.

Dr. Anka G. Ehrhardt is a biophysicist with a doctorate degree in human physiology. She is currently working in the United States building and directing a team applying the latest technologies in support of the development of new live saving drugs.

Velvet Revolution in Biomarkers, Science and Business Drivers in Clinical Biomarkers

Dr. Tirotta has been an active member of Miami Children’s Hospital medical staff since 1991, practicing with the Department of Anesthesiology; he has served as the Director of Cardiac appointment with the Department of Anesthesiology at The University of Miami School of Medicine. Dr. Tirotta received his BA from Cornell University in 1982 and his MD from New York University School of Medicine in 1986. He also received an MBA degree from Columbia University in 1999. Dr. Tirotta completed his internship in Internal Medicine at SUNY at Stony Brook in 1987. He completed his residency training in anesthesiology at the University of Miami/Jackson Memorial Hospital in 1990; he sub-specialized in pediatric and cardiovascular anesthesia, including heart transplantation. He has been the Principal Investigator on a number of clinical drug/device trials, including on the ONQ Pain Buster, the muscle relaxant Zemuron, the procoagulant RiaSTAP, the Cardiotronic NICOM device and the AirPurge.

Cardiovascular anesthesia including heart transplantation

Pillhun Son earned his PhD from Texas Tech University in Organic and Computational Chemistry and then moved on to work on Material Science and Physical Chemsitry during his Postdoc. He has worked on several database building and information solution initiatives for CAS, including, CASREACT (CAS’s premier reaction database) and the all new Formulations information solution (set to launch mid 2017). Most recently, Pill also acheived a MS in Information Systems from Northwestern University.

Material Science and Physical Chemsitry

Anna Szemik-Hojniak is an associate professor (Molecular Photophysics), employed at the Faculty of Chemistry of the University of Wroclaw (Poland). She received her Ph.D in Radiochemistry and her post-doctoral research work she conducted in Belgium [ULB(Phys. Chem)-Solvay Found, dir. Noblist, prof.I.Prigogine; KULeuven-Radiochem.(Inst.Nucl.Sci.,Belg.At.En.Com.) and France (Centr, Nucl. Res,Strasbourg-CNRS). Her scientific interest is in Time-Resolved Emission Spectroscopy (Excited State Electron and Proton Transfer) of organic compounds for high - tech and Pharmaceutical Industry. Dr Szemik performs intensive internat. scientific collaboration with the research groups from Holland (awarded by KNAW and NOW, Europ.Laser Centre), Germany (Berlin), France (Saclay), Russia and Israel. In 2005, at the Faculty of Chemistry of the University of Wroclaw (Poland) she opened a new Laborarory of Molecular Photophysics. Since 1996, she participates in ICWES conferences (International Conference of Women Engineers and Scientists) and during the last 9 years she served as INWES Board Director (“Distinguished Service Award”-2011). In 2007, she organized International Symposium for Women Scientists and Engineers of New EU Countries and East Europe “Strategies for a Highly Skilled Global Workforce” (Letters of Congrats from EC-Directorate of Women in Science and from the Min.Sci.High Educ,-Poland). Anna publishes both the professional papers and those on Women in Science. She cooperates with EC (Directorate “Women in Research and Innovations”) for “Science: it is a girl thing” project (Letter of Congrats from the Polish Ministry of Science and High Education).

Pharmaceutical Industry, Excited State Electron and Proton Transfer

Dr O’Driscoll is a pharmacist with a PhD in microbiology and working as Professor in Robert Gordon University, Aberdeen since 2010. Her key research areas are novel antimicrobials, veterinary pharmacy, contact lenses, aseptic suite working and contamination control and water treatment.

Novel antimicrobials, Veterinary pharmacy, Pharmaceutical Industry

Pierre A. MORGON is Chief Executive Officer of AJ Biologics and Regional Partner for Switzerland at Mérieux Développement, and the Founder of MRGN Advisors. He is also Non-Executive Director to the Board of Theradiag as well as to the Board of Eurocine Vaccines. He holds a Doctorate of Pharmacy, a Master in Business Law and a MBA. He is also an alumnus of INSEAD, IMD and MCE executive programs. Pierre has over 28 years of experience in the pharmaceutical and biological industry and in healthcare IT, in marketing positions up to C-level global marketing strategy, and in operations up to general management. He has acquired direct experience with blockbuster products in diverse markets (primary care, specialty care, hospital, vaccines, and biotechnology), geographies (US, Europe, Japan, China, India, Emerging Markets) and organizations.

Pharmaceutical, biological industry and in healthcare

Dr Zi (Sophia) Gu is a Lecturer and National Health and Medical Research Council (NHMRC) Early Career Fellow in the School of Chemical Engineering at University of New South Wales (UNSW), Sydney. She obtained PhD from Australian Institute for Bioengineering and Nanotechnology at The University of Queensland (UQ), Australia, in 2011, and she was awarded a NHMRC EC Fellowship in 2013 when she started her independent research at UQ prior to joining UNSW in 2016. Sophia has been working in multidisciplinary research areas that combine the knowledge and skills across nanotechnology and biomedicine, and has developed a targeted anti-restenotic therapy and built inorganic nanoparticle platforms for diagnosing and treating diseases. She published in high-impact journals including Advanced Materials, Biomaterials, Chemistry of Materials, Materials Horizons, and Journal of Controlled Release etc. Her recent awards include The Monash Engineering Women’s Leadership Award and Deputy Vice-Chancellor (Academic) Award. Her research group focuses on developing multifunctional nanomaterials for theranostic application (disease therapy and diagnosis

Nanoparticles for cancer treatment and diagnosis

Satyanarayana Somavarapu move to England came with the award of a Commonwealth Fellowship from the Association of Commonwealth Universities and he undertook a PhD at the University of Aston in Birmingham. In 2005 he was appointed as Academic Fellow at The School of Pharmacy and became a lecturer in 2010. He has over hundread publications, including fifty journal articles, over fifty peer-reviewed abstracts and several international conference presentations. He also has six patents on vaccine formulations. His research focus is on designing, understanding & developing technologies for novel nanocarrier systems in overcoming biological barriers for the targeted delivery of small therapeutic molecules and macromolecules (proteins, peptides, siRNA, miRNA) via the pulmonary route in the treatment of lung diseases (lung cancer, asthma, COPD) and ocular conditions.

Designing, understanding & developing technologies for novel nanocarrier systems in overcoming biological barriers for the targeted delivery of small therapeutic molecules and macromolecules (proteins, peptides, siRNA, miRNA) via the pulmonary route in the treatment of lung diseases (lung cancer, asthma, COPD) and ocular conditions.